Awareness and Use of Maternal Serum Screening Among Women From the St. John's Region of Newfoundland and Labrador

Journal of Obstetrics and Gynaecology Canada

Volumn 29, Issue 8, 2007, Pages 630-634

  Cavanagh, Jonathan ^a   Mathews, Maria ^a   Crane, Joan ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Maternal serum screening; Prenatal care; Women

Indexed keywords

ADULT; AGE; ARTICLE; AWARENESS; CANADA; CHILDBIRTH; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MATERNAL SERUM SCREENING TEST; OUTCOME ASSESSMENT; PATIENT EDUCATION; PATIENT PREFERENCE; PREGNANCY; WOMEN'S HEALTH; ATTITUDE TO HEALTH; BLOOD; CHROMOSOME 18; COMPARATIVE STUDY; DOWN SYNDROME; MASS SCREENING; NEURAL TUBE DEFECT; PRENATAL DIAGNOSIS; SECOND TRIMESTER PREGNANCY; TRISOMY;

ADULT; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MASS SCREENING; NEURAL TUBE DEFECTS; NEWFOUNDLAND; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; TRISOMY;

EID: 35248884489     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32555-5     Document Type: Article

References (13)

1. Wald N.J., Cuckle H.S., Densem J.W. Maternal serum screening for Down's Syndrome in early pregnancy. BMJ 1988, 297:883-887.
2. Canadian Task Force on the Periodic Health Examination Periodic Health Examination (CTFPHE), 1994 update:3. Primary and secondary prevention of neural tube defects. CMAJ 1994, 151:159-166.
3. Johnson J.-A., Summers A. Prenatal genetic screening for Down syndrome and open neural tube defects using maternal serum markers screening. SOGC Committee Opinion No. 79. J Soc Obstet Gynaecol Can 1999, 21:887-891.
4. Crane J., Sun C., Hutchens D., Crowley M. The epidemiology of neural tubes defects in Newfoundland and Labrador. J Soc of Obstet Gynaecol Can 2001, 23:510-514.
5. Chandra S., Crane J., Hutchinson D., Bennett K., O'Grady T., Duff A. Maternal serum screening: practice patterns of physicians in Newfoundland. J Obstet Gynecol Can 2003, 25:825-829.
6. Cavanagh J.P., Mathews M. Maternal Serum Screening in Newfoundland and Labrador. Can Fam Physician 2006, 52:1268-1296.
7. Permaul-Woods J.A., Carroll J.C., Reid A.J., Woodward C.A., Ryan G., Domb S., et al. Going the distance: the influence of practice location on the Ontario Maternal Serum Screening Program. CMAJ 1999, 161:381-385.
8. Chodriker B.N., Evans J.A. Maternal serum AFP screening programs: the Manitoba experience. Current practice of prenatal diagnosis in Canada Vol. 13 of Research studies 1993, 535-610. Royal Commission on New Reproductive Technologies, Ottawa.
9. Carroll J.C., Reid A.J., Woodward C.A., Permaul-Woods J.A., Domb S., Ryan G., et al. Ontario Maternal Serum Screening Program: practices, knowledge and opinions of health care providers. CMAJ 1997, 156:775-784.
10. Newfoundland and Labrador Center for Health Information Live Birth Trends-Community and Integrated Health Boards, Newfoundland and Labrador 1996-2000 2001, Newfoundland and Labrador Center for Health Information, St. Johns.
11. Goel V., Glazier R., Summer A., Holzapfel S. Psychological outcomes following maternal serum screening: a cohort study. CMAJ 1998, 159:651-656.
12. Carroll J.C., Browne J.B., Reid A.J., Pugh P. Women's experience of maternal serum screening. Canadian Family Physician. 2000, 46:614-620.
13. Van den Berg M., Timmermans D.R.M., Kleinvald J.H., Garcia E., van Vugt J.M.G., van der Wal G. Accepting or declining the offer of prenatal screening for congenital defects: uptake and women's reasons. Prenatal Diagnosis 2005, 25:84-90.